People · Operator
Named in public records as an officer, director or promoter · active 2011–2024 · Biotechnology, Software / Tech, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Seaport Therapeutics, Inc. | — | Biotechnology | Series D+ | $225.9M | $2.2B | 2024 |
| Akili Interactive Labs, Inc. | — | Software / Tech | Series D+ | $165.0M | $2.8B | 2018 |
| Gelesis Inc | — | Biotechnology | Series B | $37.7M | $1.3B | 2011 |
| Tal Medical Inc. | — | Other Health Care | Pre-Seed | $700K | $21.6M | 2011 |
Eric Elenko at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Eric Elenko on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Daphne Zohar | 2 | 4 |
| Steven Paul | 2 | 3 |
| Rishi Gupta | 1 | 12 |
| Elon Boms | 1 | 10 |
| James I. Healy | 1 | 7 |
| Joichi Ito | 1 | 7 |
| John Spinale | 1 | 6 |
| Robert Forrester | 1 | 4 |
| Bharatt Chowrira | 1 | 3 |
| Robert Perez | 1 | 3 |
| Meghan Fitzgerald | 1 | 2 |
| Elliot Maltz | 1 | 2 |
| John LaMattina | 1 | 2 |
| Eric Green | 1 | 2 |
| Yishai Zohar | 1 | 2 |
| Mendy Axelrad | 1 | 1 |
| Michael Chen | 1 | 1 |
| Lana Gladstein | 1 | 1 |
| Antony Loebel | 1 | 1 |
| David I. Wheadon | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.